Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease

B. Rodríguez-Sánchez, S. Daugbjerg, L. M. Peña-Longobardo, J. Oliva-Moreno, I. Aranda-Reneo (), A. Cicchetti and J. López-Bastida
Additional contact information
B. Rodríguez-Sánchez: University Complutense of Madrid
S. Daugbjerg: Universitá Cattolica del Sacro Cuore
L. M. Peña-Longobardo: University of Castilla-La Mancha
J. Oliva-Moreno: University of Castilla-La Mancha
I. Aranda-Reneo: University of Castilla-La Mancha
A. Cicchetti: Universitá Cattolica del Sacro Cuore
J. López-Bastida: Universidad Castilla-La Mancha

The European Journal of Health Economics, 2023, vol. 24, issue 2, No 9, 247-277

Abstract: Abstract Background Multiple sclerosis imposes a heavy burden on the person who suffers from it and on the relatives, due to the caregiving load involved. The objective was to analyse whether the inclusion of social costs in economic evaluations of multiple sclerosis-related interventions changed results and/or conclusions. Methods A systematic review was launched using Medline and the Cost-Effectiveness Analysis Registry of Tufts University (2000–2019). Included studies should: (1) be an original study published in a scientific journal, (2) be an economic evaluation of any multiple sclerosis-related intervention, (3) include productivity losses and/or informal care costs (social costs), (4) be written in English, (5) use quality-adjusted life years as outcome, and (6) separate the results according to the perspective applied. Results Twenty-nine articles were selected, resulting in 67 economic evaluation estimations. Social costs were included in 47% of the studies. Productivity losses were assessed in 90% of the estimations (the human capital approach was the most frequently used method), whereas informal care costs were included in nearly two-thirds of the estimations (applying the opportunity and the replacement-cost methods equally). The inclusion of social costs modified the figures for incremental costs in 15 estimations, leading to a change in the conclusions in 10 estimations, 6 of them changing from not recommended from the healthcare perspective to implemented from the societal perspective. The inclusion of social costs also altered the results from cost-effective to dominant in five additional estimations. Conclusions The inclusion of social costs affected the results/conclusions in multiple sclerosis-related interventions, helping to identify the most appropriate interventions for reducing its economic burden from a broader perspective.

Keywords: Economic evaluation; Health technology assessment; Informal care; Productivity losses; Multiple sclerosis; Societal perspective; Social costs; Cost-effectiveness; Cost-utility (search for similar items in EconPapers)
JEL-codes: D61 H0 I11 I15 I18 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-022-01471-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01471-9

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-022-01471-9

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().